CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Clinical trial NCT06035744 · TERMINATED
Trial details
- NCT number
- NCT06035744
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2026-06-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.